Opportunity for Choice in the National Down’s Syndrome Screening Programme (NDSSP)

Presented by:Nancy L. Chung

The partners

The NHS FASP

• Established in 1996.

• National lead for antenatal screening for chromosomal and structural abnormalities.

– Down’s syndrome screening– 18+0-20+6 week ultrasound scan

• Accessibility• Equality• Quality• Choice

Down’s syndrome screening

Commissioning tool

Women with singleton pregnancy at 10 weeks

Spontaneous miscarriage before screening offered

Offered screening

Spontaneous miscarriage

Accept screening test

Decline screening test

High risk result

Low risk result

Down’s birth

Other birth

Go to 1

Accept CVS or amniocentesis

Decline CVS or amniocentesis

Positive test

Negative test

No procedural related miscarriage

Procedural related miscarriage

Go to 1

Accept TOP

Decline TOP

Go to 1

Live Birth

Go to 1

10-14/16 weeks

10 weeks To term

NHS FASP benefits

PenTAG benefits

(Peninsula Collaborations for Leadership in Applied Health Research and Care)

Associate benefits

Health economics

ModellingUK health care system

Conclusion

• Project is now in the pilot phase.

• Overwhelmingly positive response.

• Interest in sharing the tool and transfer to other UK screening programmes.

• National and international interest in the project.

• Setting FASP as an innovator.

Nancy L. Chung, BSc (Kinesiology), MBA, MHSA

NHS FASP Innovation CentreRennes DriveUniversity of ExeterExeterDevonEX4 3AG

nancy.chung@ansnsc.co.uk

Thank you

http://fetalanomaly.screening.nhs.uk/

http://sites.pcmd.ac.uk/pentag/main.php?c=welcome

Opportunity for Choice in the National Down’s Syndrome Screening Programme (NDSSP)

Documents

Transcript of Opportunity for Choice in the National Down’s Syndrome Screening Programme (NDSSP)

Screening for Down’s syndrome FAQ’s Dr Sheila Balakrishnan MD DNB FRCOG FICOG Prof in OBGYN Medical College Trivandrum.

Congenital heart defects among Down’s syndrome cases: an ...

EVIDENCE REVIEW - nuffieldbioethics.org · EVIDENCE REVIEW . Decision-Making by Expectant Parents: NIPT, NIPD, and Current Methods of Prenatal Screening for Down’s Syndrome . September

Down’s Syndrome and Pulmonary Arterial … SYNDROME.pdfChildren with Down’s syndrome (DS) are at an increased risk of developing pulmonary arterial hypertension (PAH) due to multiple

EVIDENCE REVIEW - Nuffield Council on Bioethics · NIPT, NIPD, and Current Methods of Prenatal Screening for Down’s Syndrome . September 2016 . Gareth M. Thomas . Cardiff University

ENT Considerations in Down’s Syndrome - · PDF fileENT Considerations in Down’s Syndrome ... Otorrhea, persistent perforation, cholesteatoma ... Retrospective case control study

Examples of Sound Screening: Neural Tube Defects and Down’s Syndrome

Down’s Syndrome - Case Series Down’s syndrome (DS) is an easily recognized congenital, autosomal anomaly characterized by generalized physical and mental deficiencies. It affects

Getting to know a baby with Down’s syndrome

EF Deﬁcits Across Disabili1es · • Turner’s Syndrome • Klinefelter Syndrome • Fragile X • Down’s Syndrome Assessing Execu1ve Func1oning Wisconsin Card Sort Tower of

Social cognition in children with Down’s syndrome ... · that may be unique to Down’s syndrome, and high-light areas in which critical data are missing. Along with outlining some

Do Now: List 5 facts you know about people with Down’s Syndrome.

Down’s Syndrome and Alzheimer’s Disease - dsagsl.org · 4 Life expectancy and ageing in people with Down’s syndrome The average life expectancy of people in the general population

Draft Patient Information FIRST TRIMESTER SCREENING CLINIC · Patient information: First trimester screening clinic This leaflet contains useful information about Down’s Syndrome

Epidemiological Monitoring and Quality Control of Nuchal Translucency Jack Canick Intensive Course on Screening for Down’s Syndrome Wolfson Institute of.

Down’s syndrome

Role of astroglia in Down’s syndrome revealed by patient ... · Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells ... own’s

The linguistic profile of Down’s syndrome subjects ... linguistic profile of Down’s syndrome subjects: evidence from wh-movement construction ... inherent inability to adopt an

NHS fetal anomaly screening programme laboratory handbook · Effect of ‘vanished twin’ on biochemical markers used in screening for Down’s syndrome, Edwards’ syndrome and

PRENATAL SCREENING FOR FETAL ANEUPLOIDY, · PDF filePRENATAL SCREENING FOR FETAL ANEUPLOIDY, DOWN’S SYNDROME, ... course of development and causes the characteristics associated